Alieh Gholaminejad

593 total citations
21 papers, 422 citations indexed

About

Alieh Gholaminejad is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Alieh Gholaminejad has authored 21 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Nephrology and 5 papers in Cancer Research. Recurrent topics in Alieh Gholaminejad's work include Chronic Kidney Disease and Diabetes (7 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Alieh Gholaminejad is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Alieh Gholaminejad collaborates with scholars based in Iran, United States and Sweden. Alieh Gholaminejad's co-authors include Hossein Abdul Tehrani, Mohammad Gholami Fesharaki, Amir Roointan, Nahid Shoaie, Fatemeh Jahanpeyma, Mostafa Azimzadeh, Yousof Gheisari, Maryam Daneshpour, Seyyed Mehdi Khoshfetrat and Sara Mahshid and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Diabetes Research and Clinical Practice.

In The Last Decade

Alieh Gholaminejad

19 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alieh Gholaminejad Iran 9 191 107 96 80 61 21 422
Minghua Jiang China 12 237 1.2× 69 0.6× 68 0.7× 31 0.4× 95 1.6× 52 526
Shujun Yan China 10 212 1.1× 78 0.7× 133 1.4× 10 0.1× 19 0.3× 24 439
Ahmed H. Zedan Denmark 10 151 0.8× 35 0.3× 133 1.4× 5 0.1× 52 0.9× 26 457
Zhongchuan Wang China 14 171 0.9× 59 0.6× 66 0.7× 8 0.1× 30 0.5× 26 533
Na Yin China 11 215 1.1× 35 0.3× 65 0.7× 7 0.1× 43 0.7× 18 465
Haizhi Qi China 16 400 2.1× 52 0.5× 174 1.8× 6 0.1× 102 1.7× 32 636
Muzhou Teng China 14 196 1.0× 58 0.5× 66 0.7× 12 0.1× 141 2.3× 32 527
Kittiphong Paiboonsukwong Thailand 11 180 0.9× 61 0.6× 33 0.3× 3 0.0× 50 0.8× 37 440

Countries citing papers authored by Alieh Gholaminejad

Since Specialization
Citations

This map shows the geographic impact of Alieh Gholaminejad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alieh Gholaminejad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alieh Gholaminejad more than expected).

Fields of papers citing papers by Alieh Gholaminejad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alieh Gholaminejad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alieh Gholaminejad. The network helps show where Alieh Gholaminejad may publish in the future.

Co-authorship network of co-authors of Alieh Gholaminejad

This figure shows the co-authorship network connecting the top 25 collaborators of Alieh Gholaminejad. A scholar is included among the top collaborators of Alieh Gholaminejad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alieh Gholaminejad. Alieh Gholaminejad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eskandari, Mehdi, et al.. (2025). Effect of creatine supplementation on kidney function: a systematic review and meta-analysis. BMC Nephrology. 26(1). 622–622.
3.
Gholaminejad, Alieh, et al.. (2023). Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets. Kidney & Blood Pressure Research. 48(1). 135–150. 3 indexed citations
5.
Roointan, Amir, et al.. (2023). Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets. Nefrología (English Edition). 43(5). 575–586. 7 indexed citations
6.
7.
Roointan, Amir, et al.. (2023). Metabolome panels as potential noninvasive biomarkers for primary glomerulonephritis sub-types: meta-analysis of profiling metabolomics studies. Scientific Reports. 13(1). 20325–20325. 3 indexed citations
8.
Masoudi‐Sobhanzadeh, Yosef, Alieh Gholaminejad, Yousof Gheisari, & Amir Roointan. (2022). Discovering driver nodes in chronic kidney disease-related networks using Trader as a newly developed algorithm. Computers in Biology and Medicine. 148. 105892–105892. 5 indexed citations
9.
Gholaminejad, Alieh, Shiva Moein, Amir Roointan, et al.. (2022). Circulating β2 and α1 microglobulins predict progression of nephropathy in diabetic patients: a meta‐analysis of prospective cohort studies. Acta Diabetologica. 59(11). 1417–1427. 6 indexed citations
10.
Farmand, Maryam, et al.. (2022). Carbon nanostructures: a comprehensive review of potential applications and toxic effects. 3 Biotech. 12(8). 159–159. 29 indexed citations
11.
Gholaminejad, Alieh, et al.. (2022). An Integrative in silico Study to Discover Key Drivers in Pathogenicity of Focal and Segmental Glomerulosclerosis. Kidney & Blood Pressure Research. 47(6). 410–422. 6 indexed citations
12.
Roointan, Amir, et al.. (2022). Candidate MicroRNA Biomarkers in Lupus Nephritis: A Meta-analysis of Profiling Studies in Kidney, Blood and Urine Samples. Molecular Diagnosis & Therapy. 27(2). 141–158. 9 indexed citations
13.
Roointan, Amir, et al.. (2022). Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets. SHILAP Revista de lepidopterología. 43(5). 575–586. 7 indexed citations
14.
Roointan, Amir, Yousof Gheisari, Kelly L. Hudkins, & Alieh Gholaminejad. (2021). Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies. Nutrition Metabolism and Cardiovascular Diseases. 31(8). 2253–2272. 34 indexed citations
15.
Gholaminejad, Alieh, et al.. (2021). A meta-analysis of microRNA expression profiling studies in heart failure. Heart Failure Reviews. 26(4). 997–1021. 31 indexed citations
16.
Gholaminejad, Alieh, et al.. (2021). Comprehensive analysis of IgA nephropathy expression profiles: identification of potential biomarkers and therapeutic agents. BMC Nephrology. 22(1). 137–137. 11 indexed citations
17.
Gholaminejad, Alieh, Mohammad Fathalipour, & Amir Roointan. (2021). Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm. BMC Nephrology. 22(1). 245–245. 17 indexed citations
18.
Gholaminejad, Alieh, Amir Roointan, & Yousof Gheisari. (2021). Transmembrane signaling molecules play a key role in the pathogenesis of IgA nephropathy: a weighted gene co-expression network analysis study. BMC Immunology. 22(1). 6 indexed citations
19.
Shoaie, Nahid, Maryam Daneshpour, Mostafa Azimzadeh, et al.. (2019). Electrochemical sensors and biosensors based on the use of polyaniline and its nanocomposites: a review on recent advances. Microchimica Acta. 186(7). 465–465. 150 indexed citations
20.
Gholaminejad, Alieh, Hossein Abdul Tehrani, & Mohammad Gholami Fesharaki. (2018). Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies. Journal of Nephrology. 31(6). 813–831. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026